Search Results - "SAVES, M"

Refine Results
  1. 1

    The French National Mesothelioma Surveillance Program by Goldberg, M, Imbernon, E, Rolland, P, Soit Ilg, A Gilg, Savès, M, de Quillacq, A, Frenay, C, Chamming’s, S, Arveux, P, Boutin, C, Launoy, G, Pairon, J C, Astoul, P, Galateau-Sallé, F, Brochard, P

    “…Objectives: The French National Mesothelioma Surveillance Program (NMSP) was established in 1998 by the National Institute for Health Surveillance (InVS). Its…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Dilemma, an innovative public health scientific animation for the youth, France, 2022 by Arsandaux, J, Savès, M, Ouaraz, C, El Hajj, Z, Moulin, C, Prévot-Held, M, Joly, P, Montagni, I, Pariente, A, Mathoulin-Pelissier, S

    Published in European journal of public health (24-10-2023)
    “…Abstract Background The spread of disinformation and institutions distrust increases individuals difficulty to adhere to public health recommendations. How…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Early evolution of plasma soluble TNF-alpha p75 receptor as a marker of progression in treated HIV-infected patients by Morlat, P, Pereira, E, Clayette, P, Derreudre-Bosquet, N, Ecobichon, J-L, Benveniste, O, Saves, M, Leport, C

    Published in AIDS research and human retroviruses (01-11-2008)
    “…Abstract We evaluated the prognostic value of different mediators of inflammation: TNF-alpha and its soluble receptor p75, platelet-activating factor, and…”
    Get more information
    Journal Article
  7. 7

    Sex differences in HIV-1 viral load and TNF-α plasmatic level? by SAVES, M, MORLAT, P, CHENE, G, DUMON, B, PEUCHANT, E

    Published in AIDS (London) (30-07-1999)
    “…The difference in plasma HIV-1 viral load according to sex is a current source of debate. Recently, lower viral load measurements have been shown in women in a…”
    Get full text
    Journal Article
  8. 8

    Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy by DURAN, Ségolène, SAVES, Marianne, SPIRE, Bruno, CAILLETON, Valérie, SOBEL, Alain, CARRIERI, Patrizia, SALMON, Dominique, MOATTI, Jean-Paul, LEPORT, Catherine

    Published in AIDS (London) (07-12-2001)
    “…In a sample of 277 patients included in the French APROCO cohort study who were initially adherent at follow-up visit 4 months after initiation of a protease…”
    Get full text
    Journal Article
  9. 9

    Health related quality of life and lipodystrophy syndrome among HIV-infected patients by Préau, M, Bouhnik, A-D, Spire, B, Leport, C, Saves, M, Picard, O, Reynes, J, Salmon, D, Dellamonica, P, Raffi, F, Morin, M, Aproco-Copilote, Etlegrouped'étude

    Published in Encéphale (01-10-2006)
    “…The aim of this work is to show to what extent a psychosocial evaluation can lead bring to comprehension of the subjectivity of Quality of Life (QoL) among…”
    Get more information
    Journal Article
  10. 10

    Statistical and epidemiological methods used in biomedical research: implications for initial medical education by Picat, M-Q, Savès, M, Asselineau, J, Dumoulin, M, Coureau, G, Salmi, L-R, Perez, P, Chêne, G

    “…The main source of key medical information consists in original articles published in peer-reviewed biomedical journals. Reported studies use increasingly…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: The aquitaine cohort, 1996-1997 by BINQUET, C, CHENE, G, JACQMIN-GADDA, H, JOURNOT, V, SAVES, M, LACOSTE, D, DABIS, F

    Published in American journal of epidemiology (15-02-2001)
    “…After initiation of a treatment for human immunodeficiency virus type 1 infection containing a protease inhibitor, immune restoration associated with increases…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Severe hepatic cytolysis : incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998 by SAVES, M, VANDENTORREN, S, DAUCOURT, V, MARIMOUTOU, C, DUPON, M, COUZIGOU, P, BERNARD, N, MERCIE, P, DABIS, F

    Published in AIDS (London) (03-12-1999)
    “…Objective: To study hepatic cytolysis in patients treated by highly active antiretroviral therapy (HAART) with protease inhibitor or with two nucleoside…”
    Get full text
    Journal Article
  18. 18

    Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy by Savès, M., Morlat, P., Chêne, G., Peuchant, E., Pellegrin, I., Bonnet, F., Bernard, N., Lacoste, D., Salamon, R., Beylot, J.

    Published in Clinical immunology (Orlando, Fla.) (01-06-2001)
    “…We assessed the prognostic role of plasma levels of β2-microglobulin, TNF-α, sTNFR-II, and IFN-γ on the progression to AIDS in patients mostly treated with…”
    Get full text
    Journal Article
  19. 19

    Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy? by RANCINAN, Corinne, NEAU, Didier, SAVES, Marianne, LAWSON-AYAYI, Sylvie, BONNET, Fabrice, MERCIE, Patrick, DUPON, Michel, COUZIGOU, Patrice, DABIS, Francois, CHENE, Geneviève

    Published in AIDS (London) (05-07-2002)
    “…To study whether hepatitis C virus (HCV) co-infection or the severe elevation of transaminases is associated with survival after the initiation of…”
    Get full text
    Journal Article
  20. 20